Latest AlzeCure Pharma News & Updates

See the latest news and media coverage for AlzeCure Pharma. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
AlzeCure Pharma

Swedish pharmaceutical company developing Alzheimer's treatments

alzecurepharma.se
Headquarters
Stockholm, Sweden
Founded year
2016
Company type
Public company
Number of employees
15–50

Latest news about AlzeCure Pharma

Company announcements

  • AlzeCure Pharma

    AlzeCure Pharma carries out a rights issue of 30.1 MSEK

    The issue is 100% guaranteed by the main owner without cost. The funds strengthen the cash reserves for business development and license negotiations.

  • AlzeCure Pharma

    AlzeCure completes Phase Ib study of ACD856

    The last patient's last visit occurred, evaluating safety and tolerability of higher doses. Preclinical data support its use in Alzheimer’s and depression.

  • AlzeCure Pharma

    AlzeCure Pharma prepares for Phase II trial of ACD856

    CEO highlights progress, EIC grant, pain project preparations, and out-licensing focus. Annual Report 2025 released.

  • AlzeCure Pharma

    AlzeCure Pharma publishes its 2025 Annual Report

    The report highlights progress in phase II preparations for ACD856, a new Phase Ib trial, orphan drug designations for ACD440, and a SEK 58.5 million rights issue.

Unlock all announcements with a

Media coverage

Unlock all articles with a

Never miss news about AlzeCure Pharma

Track AlzeCure Pharma and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

AlzeCure Pharma competitors & trending companies

Browse news for competitors to AlzeCure Pharma and other trending companies.